Compass-logo-RGB-outlines.png
Compass Therapeutics Announces Clinical Collaboration with Merck to Evaluate CTX-471 in Combination with KEYTRUDA® (pembrolizumab)
11 oct. 2022 08h00 HE | Compass Therapeutics
BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
22157.jpg
Oral Biologics & Biosimilars Global Market to Reach $9.44 Billion by 2026 at a 15.9% CAGR
03 oct. 2022 05h13 HE | Research and Markets
Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Oral Biologics & Biosimilars Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global oral biologics &...
Global Monoclonal Antibodies Market
Global Monoclonal Antibodies (mAbs) Market Analysis Report 2022: A Projected $494.53 Billion Market by 2030
30 sept. 2022 05h58 HE | Research and Markets
Dublin, Sept. 30, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market Size, Share & Trends Analysis Report by Source Type (Chimeric, Murine, Humanized, Human), by Production Type (In...
22157.jpg
Global Biopharmaceutical Manufacturing Capacity and Production Report and Survey 2022: Compare 140+ Biomanufacturers vs CMOs; U.S. vs. European & Global Biomanufacturing
07 sept. 2022 04h43 HE | Research and Markets
Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "19th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report has been added to ResearchAndMarkets.com's offering....
Global Monoclonal Antibodies (Mabs) Market
Monoclonal Antibodies (MAbS) Global Market Report 2022: Increasing Product Launches and Regulatory Support for the Treatment of Rare Diseases to Fuel Future Growth
31 août 2022 04h28 HE | Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies (MAbS) Global Market Report 2022: By Source, By Application, By End-User" report has been added to ResearchAndMarkets.com's...
22157.jpg
Monoclonal Antibody Industry Deals & Agreements, 2015 to 2022 - Access to 1,000+ Monoclonal Antibodies Deal Records, and the Leading Deals by Value Since 2015
16 août 2022 07h53 HE | Research and Markets
Dublin, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Cancer Immunotherapy Market
Global Cancer Immunotherapy Market to Reach $90.53 Billion by 2027
09 août 2022 05h13 HE | Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Immunotherapy Market (2022-2027) by Product, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with...
Global Biologics Market
Global Biologics Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
22 juil. 2022 05h33 HE | Research and Markets
Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global Monoclonal Antibodies for Oncology Market
Monoclonal Antibodies for Oncology Global Market Report 2022
08 juil. 2022 05h43 HE | Research and Markets
Dublin, July 08, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies for Oncology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed...
22157.jpg
Global Lutetium-177 (Lu-177) Markets and Pipeline Analysis Report 2022-2028 Featuring Major Players - Curium , ITM Isotopen, MTTI, Novartis, Point Biopharma, Telix Pharma, & Y-Mabs Therapeutics
27 juin 2022 04h03 HE | Research and Markets
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "Lutetium-177 (Lu-177) Global Market and Pipeline Analysis - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. Lutetium-177...